<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec3dot4-medicines-04-00030" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">3.4. Antifungal Activity of EO</div>
 <p xmlns="http://www.w3.org/1999/xhtml">EO of 
  <span class="italic">A. millefolium</span> showed remarkable antifungal activity against all plant fungi tested (
  <a ref-type="table" rid="medicines-04-00030-t004" href="#medicines-04-00030-t004">Table 4</a>) at 5 ÂµL (1000 ppm/disc). It exhibited an inhibitory result on the development of 
  <span class="italic">R. stolonifer</span> (65.7%) 
  <span class="italic">V. dahliae</span> (56.3%), 
  <span class="italic">C. gloeosporioides</span> (60.9%), 
  <span class="italic">Botrytis cinerea</span> (50.8%), and 
  <span class="italic">Aspergillus niger</span> (40.7%). The inhibitory effects might be related to the presence of mono- (55.7%) and sesquiterpenes (36.5%) in the EO [
  <a rid="B23-medicines-04-00030" ref-type="bibr" href="#B23-medicines-04-00030">23</a>]. 
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">The MICs defined as the deepest concentrations of the EO that allows for full progress inhibition of 
  <span class="italic">R. stolonifer</span>, 
  <span class="italic">V. dahliae</span>, 
  <span class="italic">C. gloeosporioides</span>, 
  <span class="italic">B. cinerea</span>, and 
  <span class="italic">A. niger</span> were 1.6, 3.1, 3.4, 3.6, and 4.7 mg/mL, respectively (
  <a ref-type="table" rid="medicines-04-00030-t005" href="#medicines-04-00030-t005">Table 5</a>). 
  <span class="italic">R. stolonifer</span> was discovered to be the greatest sensitive fungal pathogens towards the 
  <span class="italic">A. millefolium</span> EO.
 </p>
</sec>
